CALLISTO PHARMACEUTICALS INC (CLSP) is a publicly traded company in the Unknown sector. Across all available filings, 6 corporate insiders have executed 14 transactions totaling $23.4K, demonstrating a bearish sentiment with -$23.4K in net insider flow. The most recent transaction on Jan 17, 2013 involved a transaction of 2,184,672 shares valued at $0.
No significant insider buying has been recorded for CLSP in the recent period.
No significant insider selling has been recorded for CLSP in the recent period.
Based on recent SEC filings, insider sentiment for CLSP is bearish with an Insider Alignment Score of 0/100 and a net flow of -$23.4K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at CALLISTO PHARMACEUTICALS INC (CLSP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 6 insiders are actively trading CLSP stock, having executed 14 transactions in the past 90 days. The most active insider is Christoph Bruening (Executive), who has made 7 transactions totaling $23.4K.
Get notified when executives and directors at CLSP file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 17, 2013 | Cerrone Gabriel | Executive | Disposition | 2,184,672 | $N/A | $0 | |
| Jan 17, 2013 | S. Jacob Gary | Executive | Disposition | 147,245 | $N/A | $0 | |
| Jan 17, 2013 | P. Brancaccio John | Executive | Disposition | 113,636 | $N/A | $0 | |
| Jan 17, 2013 | Johnson Randall | Executive | Disposition | 113,636 | $N/A | $0 | |
| Jan 17, 2013 | Merrill Hunter Robert | Executive | Disposition | 21,891,922 | $N/A | $0 | |
| Mar 26, 2012 | Merrill Hunter Robert | Executive | Gift | 12,000,000 | $N/A | $0 | |
| Nov 15, 2010 | Cerrone Gabriel | Executive | Purchase | 12,935 | $N/A | $0 | |
| Jan 19, 2010 | Bruening Christoph | Executive | Sale | 500 | $0.25 | $125 | |
| Jan 19, 2010 | Bruening Christoph | Executive | Sale | 14,500 | $0.22 | $3.2K | |
| Jan 13, 2010 | Bruening Christoph | Executive | Sale | 5,000 | $0.25 | $1.3K | |
| Jan 11, 2010 | Bruening Christoph | Executive | Sale | 25,000 | $0.25 | $6.3K | |
| Jan 8, 2010 | Bruening Christoph | Executive | Sale | 25,000 | $0.24 | $6.0K | |
| Jan 8, 2010 | Bruening Christoph | Executive | Sale | 25,000 | $0.22 | $5.5K | |
| Jan 8, 2010 | Bruening Christoph | Executive | Sale | 5,000 | $0.22 | $1.1K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 7 | $23.4K | 100.0% |
Disposition(D) | 5 | $0 | 0.0% |
Gift(G) | 1 | $0 | 0.0% |
Purchase(P) | 1 | $0 | 0.0% |
Insider selling pressure at CALLISTO PHARMACEUTICALS INC has increased, with 6 insiders executing 14 transactions across all time. Total sales of $23.4K significantly outpace purchases of $0, resulting in a net outflow of $23.4K. This selling activity appears largely discretionary, which may warrant closer attention from investors.